AKT1 and cancer: We further confirm our finding by ELISA-based activity studies of HDAC4, Akt and S6K1 (Fig 2D) which further confirm that mTORC2 and SIK3 are sequentially activated by IL-17 and high salt, respectively, to potentially induce a synergistic inflammatory and cell proliferation effect in cancer cells.